Shared on06 Sep 25Fair value Decreased 7.04%
Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.
Shared on30 Apr 25Fair value Increased 0.97%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on23 Apr 25Fair value Decreased 1.61%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.